SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing high volatility as investors weigh strong revenue growth and a massive $104 billion backlog against ongoing concerns regarding high capital expenditures and debt. The community remains deeply divided, with bulls pointing to accelerating AI infrastructure demand while bears express skepticism over sustained cash burn and profitability.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing significant social media activity following an earnings report that featured a revenue guidance raise and bottom-line outperformance, fueling intense debate between bulls citing AI demand and shorts highlighting governance concerns. Investors are actively discussing the stock's volatility and the disparity between its strong financial outlook and its relatively subdued market reaction.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences remains a focal point for the investment community as shareholders closely monitor the pending 80th event in the REGAL Phase 3 trial, which serves as the primary catalyst for final data analysis and potential regulatory filings. Despite recent earnings reports reflecting increased research and development spending, community discussion is dominated by the company's strong cash position, the strategic management of warrant overhangs, and the anticipation of how durable patient survival data will impact future clinical outcomes and potential partnership opportunities.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony ($UAMY) is trending following a significant quarterly revenue miss and a reduction in full-year guidance, which has fueled widespread investor frustration and concerns over management's execution. While some in the community see the current price drop as a discount for long-term holders, others are actively debating the company's reliance on government contracts and the lack of clarity regarding its strategic pivot toward domestic independence.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly Aerospace is seeing increased trading activity as investors speculate on potential government contracts and upcoming earnings, with the community closely tracking its competitive position relative to other major players in the space sector. Market participants are actively discussing the impact of broader industry developments and heavy institutional interest as the stock navigates a volatile period leading into its next financial update.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing elevated volatility as investors weigh strong earnings and data center demand against sector-wide concerns, including potential trade restrictions on optical components. The community remains divided, with many traders actively discussing the stock's long-term growth prospects as a photonics leader versus the risk of a technical correction.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors weigh explosive demand for AI infrastructure against concerns over high capital expenditures and dilution risks, with the community closely tracking upcoming earnings for validation. The stock remains a focal point for intense debate, as market participants actively bet on a potential short squeeze while monitoring the influence of high-profile short-sellers and institutional stake-building.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following a strong quarterly earnings report that featured a double beat on revenue and earnings, driven by robust store traffic and growth in same-restaurant sales. The community is actively debating the stock's premium valuation versus its long-term potential as a category-leading national brand, while investors closely monitor institutional sentiment and guidance.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following impressive quarterly earnings that featured strong revenue growth and increased financial guidance, driving significant investor optimism. The community is actively discussing the company's manufacturing expansion and its role in critical defense and aerospace supply chains, with many expressing bullish sentiment on its long-term growth potential.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNav is trending due to heightened investor anticipation surrounding the FCC's potential approval of its spectrum reconfiguration, which remains a key catalyst despite recent legislative and industry-driven delays. The community is actively debating the significance of ongoing regulatory processes and spectrum valuation, with sentiment currently split between high-conviction bullishness regarding the company's PNT technology and concerns over the complex, long-term political hurdles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adds three semiconductor-focused leveraged ETFs, including first-to-market funds on MRAM and SITMNEW YORK, Aug. 11, 2026 /PRNewswire/ -- Tradr ETFs,&nbsp;a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of three new leveraged single-stock ETFs. The Cboe-listed funds seek to deliver two times long (200%) the daily performance of a specific underlying stock.The following ETFs are expected to open for trading today:<ul><li>Tradr 2X Long MRAM Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4748274-1&amp;h=4101355536&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fmrax&amp;a=MRAX">MRAX</a>) – tracks Everspin Technologies, Inc. (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-expands-lineup-with-leveraged-funds-on-everspin-sitime-and-umc-302846374.html#financial-modal">MRAM</a>) &nbsp;</li><li>Tradr 2X Long SITM Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4748274-1&amp;h=3821068158&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fsitx&amp;a=SITX">SITX</a>) – tracks SiTime Corporation (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-expands-lineup-with-leveraged-funds-on-everspin-sitime-and-umc-302846374.html#financial-modal">SITM</a>) &nbsp;</li><li>Tradr 2X Long UMC Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4748274-1&amp;h=1981510544&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fumcu&amp;a=UMCU">UMCU</a>) – tracks United Microelectronics Corp. (NYSE: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-expands-lineup-with-leveraged-funds-on-everspin-sitime-and-umc-302846374.html#financial-modal">UMC</a>)</li></ul>"Innovation in semiconductors extends well beyond the industry's high profile stocks, and traders are increasingly looking for ways to express views on emerging technology leaders," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "These launches expand on our already deep suite of strategies covering semi names such as NVIDIA, Astera Labs, Cerebras, onsemi, Rambus and NXPI, and we are excited to offer first-to-market ETFs on Everspin and SiTime."With these new products, Tradr's product line now comprises 75 leveraged ETFs. Its strategies can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4748274-1&amp;h=275953535&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4748274-1&amp;h=2730034158&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>&nbsp;are designed for sophisticated investors and professional traders&nbsp;who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATION Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4748274-1&amp;h=275953535&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI001021SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Tradr Expands Lineup with Leveraged Funds on Everspin, SiTime and UMC

Tradr ETFs launches 3 new 2X leveraged single-stock ETFs tracking Everspin (MRAM), SiTime (SITM), and UMC, expanding its semiconductor lineup to 75 funds

Others

Tradr 2X Long MRAM Daily ETF

Tradr 2X Long SITM Daily ETF

Tradr 2X Long UMC Daily ETF

In-house production strengthens ZenaDrone’s path to Blue UAS Certification as federal restrictions on Chinese-made drones open a significant market opportunity for compliant American manufacturersVancouver, British Columbia, (August 11, 2026) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that its U.S.-based subsidiary ZenaDrone has commenced flight testing of its custom-designed printed circuit boards (PCBs) at its UAE manufacturing and testing facility, integrating the proprietary boards directly into its ZenaDrone 1000 and IQ Nano drone platforms. The boards are designed and manufactured at the Company’s Taiwan-based Spider Vision Sensors (SVS) subsidiary, then shipped to UAE for integration and flight validation, representing the latest step in ZenaTech’s strategy to build a vertically integrated, defense-grade supply chain positioned to capture growing U.S. government demand for NDAA-compliant drone technology. “Flight testing our in-house circuit boards is a proof point in our vertical integration strategy, which we believe is central to long-term shareholder value,” said Shaun Passley, Ph.D., ZenaTech CEO. “Designing and manufacturing our own boards through Spider Vision Sensors, rather than depending on third-party or foreign suppliers, gives us control over cost, quality, and our timeline to Blue UAS certification, considered a gateway to higher-volume procurement and U.S. Defense Department and NATO contracts. With Chinese-made drones being pushed out of the federal market, we believe ZenaDrone is well positioned to capture a meaningful share of a U.S. defense drone market being reshaped in our favor.”This milestone advances ZenaDrone’s vertical integration strategy of bringing core electronics design and manufacturing fully in-house. The rationale is threefold: greater supply chain resilience amid geopolitical and export-control uncertainty; improved gross margin potential from reduced reliance on external suppliers; and a shorter design-to-deployment cycle through direct control over circuit board design and testing. Successful validation will pave the way for components to be deployed across ZenaDrone’s full platform lineup including the ZenaDrone 1000, IQ series, and Counter UAS products.The custom PCBs are produced at Spider Vision Sensors’ 16,000-square-foot Taiwan facility, which also is in the processes of manufacturing components such as cameras, sensors and motors consolidating key supply chain points under direct ZenaTech ownership. Taiwan’s strength as an electronics hub supports high-precision manufacturing while reducing reliance on Chinese-made components. Taiwan is not designated a “covered foreign country” under the NDAA — making components manufactured there eligible for use in NDAA-compliant, Blue UAS-eligible drone systems. NDAA compliance means adhering to the U.S. National Defense Authorization Act, which restricts foreign-made electronics, including Chinese-sourced components, in defense equipment. Blue UAS certification is a prerequisite for direct DoD and federal agency procurement and requires component-level traceability, including for PCBs. ZenaDrone currently has four drones in this process to achieve certification. This comes as the American Security Drone Act and new Federal Communications Commission (FCC) restrictions bar Chinese-made drones and components from federal use, displacing long-dominant manufacturers and creating an opportunity that management believes ZenaDrone’s vertically integrated, non-Chinese supply chain is positioned to capture. Further updates will follow as the Company progresses through additional flight validation milestones. About ZenaTech <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.zenatech.com/">ZenaTech</a>, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform industrial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.droneasaservice.com/?__hstc=67789070.934af5cce603ec4e4de12324e5f9c99d.1781012960112.1786023208066.1786453029439.17&amp;__hssc=67789070.2.1786453029439&amp;__hsfp=ca4570f25e16b1dca3517a03786210e0"> Drone as a Service</a> (DaaS) business, and a separate enterprise SaaS division of multiple software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, and Asia, ZenaTech is advancing AI drones for agriculture and logistics, as well as ISR, cargo, and counter-UAS applications for U.S. defense and NATO allies. The Company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&amp;D initiatives.About ZenaDrone <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://www.zenadrone.com/?__hstc=67789070.934af5cce603ec4e4de12324e5f9c99d.1781012960112.1786023208066.1786453029439.17&amp;__hssc=67789070.2.1786453029439&amp;__hsfp=ca4570f25e16b1dca3517a03786210e0">ZenaDrone</a>, a subsidiary of ZenaTech, develops and manufactures AI-powered multifunction autonomous drone solutions integrating machine learning, predictive analytics, and advanced computing technologies, for government, defense, and industrial applications. This includes multifunctional drones for surveying, inspections, logistics, security, and defense applications. Its product portfolio includes the<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.zenatech.com/drone-technology-solutions/"> ZenaDrone 1000</a> for ISR defense and specialized cargo, the<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.zenatech.com/drone-technology-solutions/"> IQ Nano</a> for indoor inventory management and security, the<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.zenadrone.com/zenadrone-iq-square/?__hstc=67789070.934af5cce603ec4e4de12324e5f9c99d.1781012960112.1786023208066.1786453029439.17&amp;__hssc=67789070.2.1786453029439&amp;__hsfp=ca4570f25e16b1dca3517a03786210e0"> IQ Square</a> for outdoor inspections and maintenance, the<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.zenadrone.com/iq-quad-drone/?__hstc=67789070.934af5cce603ec4e4de12324e5f9c99d.1781012960112.1786023208066.1786453029439.17&amp;__hssc=67789070.2.1786453029439&amp;__hsfp=ca4570f25e16b1dca3517a03786210e0"> IQ Quad</a> for land surveying, and the IQ Aqua for underwater applications. ZenaDrone operates three global manufacturing facilities in Arizona, Dubai, and Taiwan, and is advancing counter-UAS maritime interceptor drones and an integrated defense system.Contacts for more information: Company, Investors, and Media: Linda Montgomery ZenaTech 312-241-1415 <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:investors@zenatech.com">investors@zenatech.com</a>Investors: Michael Mason CORE IR <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:investors@zenatech.com">investors@zenatech.com</a>Safe Harbor This press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity; ZenaTech’s ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000, IQ Square and IQ Nano; ZenaTech’s ability to develop products for markets as currently contemplated; ZenaTech’s anticipated cash needs and its needs for additional financing; ZenaTech’s intention to grow the business and its operations and execution risk; expectations with respect to future operations and costs; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; political, economic, environmental, tax, security, and other risks associated with operating in emerging markets; regulatory risks; unfavorable publicity or consumer perception; difficulty in forecasting industry trends; the ability to hire key personnel; the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech’s expected business objectives for the next twelve months; ZenaTech’s ability to obtain additional funds through the sale of equity or debt commitments; investment capital and market share; the ability to complete any contemplated acquisitions; changes in the target markets; market uncertainty; ability to access additional capital, including through the listing of its securities in various jurisdictions; management of growth (plans and timing for expansion); patent infringement; litigation; applicable laws, regulations, and any amendments affecting the business of ZenaTech and other related risks and uncertainties disclosed under the heading “Risk Factors” in the Company’s Form F-1, Form 20-F and other filings filed with the United States Securities and Exchange Commission (the “SEC”) on EDGAR through the SEC’s website at www.sec.gov. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

ZenaTech’s ZenaDrone Begins In-House PCB Flight Testing, Advancing Vertical Integration Strategy Toward NDAA-Compliant Blue UAS Certification and Expanded Defense Opportunities

ZenaDrone begins flight testing in-house PCBs (via Taiwan's SVS), advancing Blue UAS certification as U.S. bars Chinese drones from federal use

ZenaTech Inc.

<h2 class="article-sub-headline">Achieved with Aeponyx, a subsidiary of Pasqal acquired less than 18 months ago, the milestone clears one of the central hardware barriers on the path to fault-tolerant, industrial-scale quantum computers</h2>PARIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Pasqal, a global leader in neutral-atom quantum computing, today announced what it, to its knowledge, believes to be a world-first: the trapping of individual atoms using laser light generated by a photonic integrated circuit (PIC). Achieved with Aeponyx, Pasqal believes this milestone demonstrates a new scalable approach to qubit control supporting future large-scale FTQC quantum processors.Neutral-atom quantum computers rely on highly focused laser beams, known as optical tweezers, to trap and control individual atoms that serve as qubits. As Pasqal pursues machines with more than 10,000 atoms and 100 logical qubits, one of the primary engineering challenges is the growing complexity of optical hardware, which today often requires large free-space optical benches. This advancement addresses this challenge by moving critical optical functions onto a photonic chip.“Building quantum computers that excel commercially means building hardware that delivers industry leading performance and can be manufactured in a scalable way,” said&nbsp;Wasiq Bokhari, Chief Executive Officer, Pasqal. “By moving qubit control onto a photonic chip, we removed what we believe to be one of the biggest barriers to scale - and we did it within 18 months of acquiring Aeponyx. We are very proud of our team for achieving this milestone.”In the demonstration, Pasqal generated four optical traps through a single photonic chip and used them to hold four individual rubidium atoms inside a quantum processing unit - what Pasqal believes is the first time trapping light delivered from a photonic chip has held atoms on a neutral-atom quantum computer. The work is part of a broader development program to generate, route and control laser light directly on-chip.In testing, the photonic-chip architecture reproduced atom trapping with performance in line with Pasqal's existing bulk-optics systems, including atom lifetimes of approximately 27.5 seconds. Pasqal believes the result validates integrated photonics as a viable building block for future neutral-atom processors, without sacrificing the quality of qubit control.Co-developed with Aeponyx's silicon-nitride photonics expertise, the platform is designed to shrink the optical footprint of future processors by as much as 50 times and to open a practical route to large-scale manufacturing, an expected advantage as the industry moves from prototypes to production.Pasqal will work to scale the photonic architecture toward the compact systems required for fault-tolerant, industrial-scale quantum computing, with a long-term target of more than 10,000 atoms and 100 logical qubits.The milestone illustrates Pasqal's efforts to beat the forefront of the race to fault-tolerant quantum computing and its strategy of owning the critical hardware layers of its stack, turning targeted moves like the Aeponyx acquisition into measurable technical and commercial advances.About PasqalPasqal is a global leader in delivering practical quantum computing at scale utilizing neutral atom technology and dedicated software for industry, science, and governments. Since its founding in 2019, Pasqal has leveraged Nobel Prize winning research to build high-performance quantum systems and cloud-ready software designed to address complex challenges in optimization, simulation, and artificial intelligence.Headquartered in France, Pasqal employs approximately 300 people and serves over 25 clients and partners, including Saudi Aramco, LG Electronics, Crédit Agricole CIB, CMA CGM, OVHcloud, Thales, IBM (Pasqal is part of the IBM Quantum Network), and Sumitomo.Backed by more than USD 300 million in total funding from leading international investors, Pasqal is pursuing a listing on Nasdaq in partnership with Bleichroeder Acquisition Corp. II (Nasdaq: BBCQ) and is accelerating the adoption of scalable, high-performance quantum computing worldwide.Forward-Looking StatementsCertain statements herein may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “might”, “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “could,” “plan,” “predict,” “project”, “forecast,” “believe,” “potential,” “seem,” “seek,” “target,” “possible,” “future,” “outlook” or similar terminology or expressions that predict or indicate future events or trends. These forward-looking statements include, but are not limited to, statements regarding future events and the proposed business combination between Bleichroeder Acquisition Corp. II (“Bleichroeder”) and Pasqal Holding SAS (“Pasqal”).These statements are based on current expectations and are not predictions of actual performance. They are provided for illustrative purposes only and must not be relied on as a guarantee, prediction or definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and are beyond the control of Bleichroeder and Pasqal. These statements are subject to known and unknown risks, uncertainties and assumptions regarding Pasqal’s business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political, social and business conditions; uncertainty or changes with respect to laws and regulations; the inability of the parties to consummate the business combination failure to realize the anticipated benefits of the business combination; the risk that the business combination disrupts Pasqal’s current plans and operations; the risk from Pasqal pursuing an emerging technology, facing significant technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal’s reliance on strategic partners and other third parties; Pasqal’s ability to maintain, protect and defend its intellectual property rights; and other risks that will be detailed from time to time in filings with the U.S. Securities and Exchange Commission (the “SEC”). The foregoing list of risk factors is not exhaustive. There may be additional risks that Pasqal and Bleichroeder presently do not know or currently believe are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Pasqal’s and/or Bleichroeder’s expectations, plans and forecasts of future events and views as of the date of this communication. While Pasqal and/or Bleichroeder may elect to update these forward-looking statements in the future, Pasqal and Bleichroeder specifically disclaim any obligation to do so.Additional Information and Where to Find ItThe business combination will be submitted to shareholders of Bleichroeder for their consideration. In connection with the business combination, Bleichroeder, Bleichroeder Acquisition France Merger Sub 2 and Pasqal jointly filed a registration statement on Form F-4 with the SEC, which was declared effective by the SEC on August 5, 2026 (as subsequently amended, the “Registration Statement”), and which includes a definitive proxy statement/prospectus. The definitive proxy statement/prospectus and certain other related documents have been mailed to Bleichroeder shareholders as of August 4, 2026, the record date established for voting on the proposed transaction, in connection with Bleichroeder’s solicitation for proxies for the vote by Bleichroeder’s shareholders in connection with the business combination and other matters described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities to be issued to Pasqal’s shareholders in connection with the completion of the business combination. This communication is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Bleichroeder has sent to its shareholders in connection with the business combination.BEFORE MAKING ANY INVESTMENT OR VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ THE REGISTRATION STATEMENT, DEFINITIVE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS AND, IN EACH CASE, ANY AMENDMENTS THERETO, FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION, RELATED TRANSACTIONS AND THE PARTIES TO THE BUSINESS COMBINATION. Shareholders of Bleichroeder may obtain copies of these documents (when available) and other documents filed with the SEC free of charge at www.sec.gov.Participants in the SolicitationBleichroeder, Pasqal and certain of their respective directors, executive officers, and other members of management, employees and consultants, under SEC rules, may be deemed participants in the solicitation of proxies from Bleichroeder’s shareholders with respect to the business combination. A list of the names of Bleichroeder’s directors and executive officers and a description of their interests in Bleichroeder and the business combination is contained in the sections entitled “Directors, Executive Officers and Corporate Governance,” “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters,” and “Certain Relationships and Related Transactions, and Director Independence” of the Annual Report filed by Bleichroeder with the SEC on March 16 2026 and the Current Report on Form 8-K filed with the SEC on May 1, 2026, each of which is available free of charge at the SEC’s website at www.sec.gov. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies from Bleichroeder’s shareholders with respect to the business combination, and their direct and indirect interests, is included in the Registration Statement and the proxy statement/prospectus. No Offer or SolicitationThis communication is for informational purposes only and is not (i) an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law nor (ii) the solicitation of any vote in any jurisdiction pursuant to the business combination or otherwise. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or exemptions therefrom. No securities commission or securities regulatory authority has in any way passed upon the merits of the business combination or the accuracy or adequacy of this communication.ContactsInvestors <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=gyUSMbxSdDmfxB5kw3GQS_5mhPi2E_3FGlM8POSDwzf2J_LubrgR619bMsvj2_HaWXV6qcD3kSKr8gKTRXiPJrJox7j5Xm_f604Aoj1v2xgF1HQROAbrAIvwde1G3XfCyZYbvGx2mloYylxc1Hhpbix6f_jsw7zmJ7NRQJF-0rp-qfC7kl3KM03ttGpkVY5OqelrfOHA0mPGJPWZvk_Dj46Odyyz6WEi9a6njrdzHJNYvkMmjMNfs7vFHi2gM4Hef9nsIXki3Y_2Z75WXRg2gg==">investors@pasqal.com</a>&nbsp;Media <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Vzf7CbTkg6N4k0304hrryrG0W0ZOgy3so2hI8EGul67EpOnrxzKenfxPik1Aju5bLUhSlqNqChMnWyGk9NTKt32TDESDxsd1kl1HLnprX8EoZo4l_PM2c1VbiJ5PK0eQ10CSpFnlTazz34UBXJttMah2lO7wwlA3n9q92hd-_PwfVoh-cXvKuwjxrSpS3ObLC-yVwWqU2tvRBDlq9BmwLHLR0wabXX42d2OUqAA-Puk=">pr@pasqal.com</a>Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Pasqal Brings Qubit Control On-Chip – Advancing the Path to Fault-Tolerant Quantum Computing at Scale

Pasqal traps atoms using laser light from a photonic chip for the first time, cutting optical hardware size and advancing scalable quantum computing

Bleichroeder Acquisition Corp II - Ordinary Shares - Class A

JACKSONVILLE, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=S3qMElfV4Vby6RHrH053GQ-ItGvY4BI-wvigLPQT2ghDC6Impwxkc11vofOZf6JHyw1yULLkFzqXFij5K5Jr8BVVK_8joTn7zijONvgqKFgqUCQxtnK8KXuxyiKatiSu">Duos Technologies Group, Inc.</a> (“Duos” or the “Company”) (<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=C1dNpmcCHG8lytfWSf1Wnv4uDETi4HBrriUUtYSILA4IE1SoVLMQZAHbzQ99STIgbdkCzl-VEbDPF_pbmjNubKshCCoIVN_0yqwNmU9ab_A=">Nasdaq: DUOT</a>), a leading provider of adaptive, modular, and scalable Edge Data Center solutions, will hold a conference call on Monday, August 17, 2026 at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2026. The Company will release its financial results after market close on Friday, August 14 via press release, which will be available in the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=p-Ttpf3gCBcw7Z5QZzoN4Q_y4MTCzLI5kzc33TuAWqJcrZcwJgyIbnxQ8fJf5kw5dLnQ5cUudbY718ORK__VZJ2neI5dcl07Be0iSfD9X5k=">Investor Relations</a> section of its website.Duos’ management will host the conference call, followed by a question-and-answer period.<figure class="table"><table><tbody><tr><td colspan="3">Conference Call Details: &nbsp;</td></tr><tr><td>&nbsp;</td><td>Date:</td><td>Monday, August 17, 2026</td></tr><tr><td>&nbsp;</td><td>Time:</td><td>4:30 p.m. Eastern time (1:30 p.m. Pacific time)</td></tr><tr><td>&nbsp;</td><td>U.S. dial-in:</td><td>+1 877-407-3088</td></tr><tr><td>&nbsp;</td><td>International:</td><td><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.incommconferencing.com/international-dial-in">Dial-In Matrix Link</a></td></tr><tr><td>&nbsp;</td><td>Confirmation:</td><td>13761911</td></tr></tbody></table></figure>Participants are encouraged to dial in 5–10 minutes prior to the start time. An operator will assist with registration.If you experience any difficulty accessing the call or wish to submit questions in advance, please contact the Company at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Qbw8pP7Ms16GX6tZhQWPHIFHv4fSGOlkClvtcGpWOq6P9KP-Q4oLGdkU7651k3EiB1zDVuIGalngUnGxx5THxCNaXdWOIew0RkQuJA2A5hE=">DUOT@duostech.com</a>. An audio replay of the call will also be available in the Investor Relations section of the Company’s website following the event.For additional information about the Company, please visit: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xYq3qhXxTktqzYjfaO6zEiPdqHpwhEU7NtQ944LGRyUxpqjxMlNmbg356ix-rSdrNf1FznhxNsvbnOSPjGFltgwk3GCWQq4bNpEnGRK6wb3XThDcG6IAoq1lSSWyOwHI">www.duostechnologies.com</a> | <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xYq3qhXxTktqzYjfaO6zEupJfNYJEJG5_aRYHerT0xJS6HtUuB8HMMyqoKuBxK3sfr7W64JAcXJmydc83wHeug==">www.duosedge.ai</a>.About Duos Technologies Group, Inc. Duos Technologies Group, Inc. (<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=C1dNpmcCHG8lytfWSf1WniJEx0E12ppgd4Cn0985v_VGnuMCpAyPP032FetWUSC5tD8qgzQ4oldCp3Xep2iVJQXzoZDeuxx7oCzmpbs7sH8=">Nasdaq: DUOT</a>), based in Jacksonville, Florida, is focused on providing and managing modular data center colocation facilities and infrastructure solutions. Through its wholly owned subsidiaries Duos Edge AI, Inc., and Duos Technology Solutions, Inc. the Company delivers high function computing infrastructure at the “Edge” designed to support high power computing facilities suitable for AI and Enterprise Computing. Duos is strategically focused on scaling its edge data center platforms in conjunction with its data center infrastructure solutions business. It provides manufacturer-agnostic sourcing, and fulfillment services to support efficient deployment of data centers and IT environments. Together, these platforms position the Company to address the growing demand for distributed digital infrastructure, while continuing to support legacy applications in Tier 3 and Tier 4 markets.For more information, visit&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xYq3qhXxTktqzYjfaO6zEtyWnlrsXwD4AEsUX-z_5-dzjzyrsfQOHVTC9nHwgLIvlOU83M2IwdiRVwR_kEr8KhuZmYvZ3JH0U74YNimeCRk=">www.duostech.com</a> and <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xYq3qhXxTktqzYjfaO6zEopaF6RUJD3fyfWsEZtWMQ8XiySyblMTT2ev6JXwoklICvABBC-QMt6wY6wTVEBprg==">www.duosedge.ai</a>.Forward-Looking Statements This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated" and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. All forward-looking statements attributable to Duos Technologies Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.Contacts Investor Relations Tom Colton &amp; Greg Bradbury Gateway Group, Inc. +1 949-574-3860 | <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Qbw8pP7Ms16GX6tZhQWPHOqXn2kEa-LI9gA2NUuVl1ObjRuA3mdrVYQNb4nonu9GEd7YM8RQxU9FI9cSmoKpVtY-fh9X21-SRFsdDzvAGW8=">DUOT@duostech.com</a>A photo accompanying this announcement is available at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=DNe1PijUPUAoCRGUFOly6wgE7oN3HUho8impGqyc54MzQf5M0163G2oV6cfT6x4I3eWRJUVgJjhwJuXxzjs8UzFlFjIkb7pWJqKJ4NZIcI9KwexfnsIQTkbueRd0lweFvDO2QtSPQyBxFCEMRRWtb15eN-pBiMqQMB5hRyYWNe1ToiQ7XrU8MvqugVIACM8uei8ZetjmZUbg-IQOVV34guCf7v8HkfzG8d4Ng9opz32_KPTlTzdKGf82Rrb3WHRHFWzD5X_acS-DQitDRhOvVw==">https://www.globenewswire.com/NewsRoom/AttachmentNg/7aaf96ae-53c4-44e9-8afa-bd27d0d4bea5</a><div><div><div><h5>Duos Technologies Group Sets First Quarter 2026 Earnings Call for Monday, August 17, 2026 at 4:30 PM ET</h5></div><div><h5>Duos Technologies Group, Inc., a provider of modular, colocation Edge and AI data centers and technology infrastructure solutions, will hold a conference call on Monday, August 17, 2026 at 4:30 p.m.</h5></div></div></div>Source: Duos Technologies Group, IncReleased August 10, 2026Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Duos Technologies Group Sets Second Quarter 2026 Earnings Call for Monday, August 17, 2026 at 4:30 PM ET

Duos Technologies (DUOT) to hold Q2 2026 earnings call Mon, Aug 17 at 4:30pm ET. Financial results release after market close Fri, Aug 14

Duos Technologies Group Inc

Call to be held Wednesday, August 12, 2026 at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern TimeCALABASAS, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc” or the "Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers, today announced that it will host an investor conference call and webcast on Wednesday, August 12, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.During the call, members of the NeOnc management team will present topline results from the Phase 2a portion of the NEO100-01 clinical trial, an open-label study of intranasal NEO100™, the Company’s proprietary formulation of purified perillyl alcohol, in patients with recurrent or progressive Grade III and Grade IV IDH1-mutant glioma.The discussion will include efficacy and safety observations from the Phase 2a portion of the NEO100-01 clinical trial and planned regulatory next steps. A question and answer session will follow the presentation.Featured Participants:<ul><li>Amir Heshmatpour, Executive Chairman, President and Chief Executive Officer &nbsp;</li><li>Thomas C. Chen, MD, PhD, Founder, Chief Medical Officer and Chief Scientific Officer &nbsp;</li><li>Josh Neman, PhD, Chief Clinical Officer</li><li>Keithly Garnett, Chief Financial Officer&nbsp;</li></ul>Conference Call Details:<ul><li>Date: Wednesday, August 12, 2026 &nbsp;</li><li>Time: 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time &nbsp;</li><li>Webcast: A live webcast can be accessed at: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=wQM080erzZYyh6XDYDSn9TT-UIkv90TnJLhPQS-aIIPM2tcNSKOO74DiVjhndqYrPbnS4EBTiOFPzH2YvXPpcv51F2R4mMc9PJbbdBshmbnfWzb5DJMUsIPKx75DkQbdSylX8LVeuHT_ne-5_SJRgubhMmuCPIuZcwHZ6DfLzk0=">https://www.webcaster5.com/Webcast/Page/3151/54410</a> or by visiting <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=wQM080erzZYyh6XDYDSn9SNB_lCf-CUvk35HHtYs1pbS1bYywTo9q9vL9TimsobHHwrNB0DqEFRmvyKI1mhHKViWPg28lp0rapRzHYc3XJc=">https://investors.neonc.com</a></li><li>Replay: A replay of the webcast will be available at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=wQM080erzZYyh6XDYDSn9SNB_lCf-CUvk35HHtYs1pbACXKcxj6WSbLcRHfy_pr-U9h3hXRp0s-EINtSJIPPq6HuuLVc96Q-WG7deDIYyZw=">https://investors.neonc.com</a>&nbsp;shortly following the conclusion of the call.<div><div><div>&nbsp;</div></div></div></li></ul>ABOUT NEONC TECHNOLOGIES HOLDINGS, INC.NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood-brain barrier. The company’s NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc’s NEO100™ and NEO212™ therapeutics are in Phase II human clinical trials and are advancing under FDA Fast-Track and Investigational New Drug (IND) status. The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California consisting of issued patents and pending applications related to NEO100, NEO212, and other products from the NeOnc patent family for multiple uses, including oncological and neurological conditions.For more about NeOnc and its pioneering technology, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=1UK2zC7zwLwlVdaymu4__HDCj8LnCmZ2dU_UJUj2r6Zf6qJusLJPrBwmYcU1wPr3lt1duulM7OBvFwYTUfjoGg==">https://neonc.com</a>.Important Cautions Regarding Forward-Looking StatementsThis press release contains "forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by terminology such as "may,” "will,” "should,” "intend,” "expect,” "plan,” "budget,” "forecast,” "anticipate,” "believe,” "estimate,” "predict,” "potential,” "continue,” "evaluating,” or similar words. Statements that contain these words should be read carefully, as they discuss our future expectations, projections of future results of operations or financial condition, or other forward-looking information.<div>Advertisement</div>Please refer to the "Risk Factors” section of our quarterly and annual reports on Form 10-Q and Form 10-K as filed with the Securities and Exchange Commission, along with other cautionary language in those reports and risk factors and other cautionary language in our subsequent filings with the Securities and Exchange Commission, which outline important risks and uncertainties. These may cause our actual results to differ materially from the forward-looking statements herein, including but not limited to the fact that results of preclinical studies and early clinical trials may not be predictive of results of future clinical trials, announced or published data from our clinical trials may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data, and our product candidates are in preclinical and clinical stages of development, are not approved for commercial sale and might never receive regulatory approval or become commercially viable.We assume no obligation to revise or update any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable securities laws and regulations."NEO100” and "NEO212” are registered trademarks of NeOnc Technologies Holdings, Inc.Company Contact:<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=bWfZVXVXUddVAKsWaVHUlqdX-G-_eZbH29Jjg7QEO_Vi0ok61Uj1-1YXXxv7RfqN-9vkGPlAH8QzJY4iJnPx_Q==">info@neonc.com</a>&nbsp;Investor Contact:Jon NugentJon Nugent Communications<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=zljz5YaxBzYDG5NP9Ei5u2wIESXW6XRpn71-DzysMSUWsV1p_3TEW7KmGGhEkn-0YOnBxXPudYwfZ85osCtT_cfp_6yDpzaQZDKbH66N0rE=">jon@jonnugent.com</a>&nbsp;205-566-3026&nbsp;This press release was published by a CLEAR® Verified individual.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

NeOnc (NTHI) hosts Aug 12 investor call on Phase 2a NEO100 glioma trial results and regulatory next steps. 8:30am ET

NeOnc Technologies Holdings Inc.

CALABASAS, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for central nervous system cancers, today announced financial results for the second quarter ended June 30, 2026, highlighted recent clinical and regulatory progress across its NEO100 and NEO212 programs, and confirmed that topline results from its fully enrolled Phase 2a NEO100 study will be presented on August 12, 2026.Amir Heshmatpour, Executive Chairman, President and Chief Executive Officer, commented:“The second quarter positioned NeOnc for an important period of clinical execution. We completed the topline analysis of our fully enrolled Phase 2a NEO100 study in recurrent IDH1-mutant high-grade glioma and look forward to presenting the results to investors on August 12. This is one of the most important clinical milestones in NeOnc’s history.“At the same time, we secured UAE IND approvals for both NEO100 and NEO212, expanding our international clinical development pathway alongside our ongoing programs in the United States. The breadth of the NEO100 authorization is particularly meaningful, covering three adult and pediatric clinical programs ranging from Phase 1 through Phase 2.“Our increased research and development investment reflects tangible clinical progress, including the addition of trial sites, expanded drug-product manufacturing, patient recruitment, pediatric development and completion of the NEO100 data analysis. Importantly, general and administrative expenses declined year over year as we continued directing resources toward the advancement of our clinical portfolio.“We also strengthened our Board with the appointment of Nasim Shomali, whose strategic, financial and operating experience will support NeOnc as we advance our programs through their next stages of development.“Looking ahead, we look forward to presenting topline results from the Phase 2a study of NEO100 in recurrent IDH1-mutant high-grade glioma on August 12, 2026. This readout represents one of the most important clinical milestones in NeOnc’s history, and we look forward to discussing the results with our shareholders.”Second Quarter and Recent HighlightsClinical and Regulatory Milestones<ul><li>NEO100 UAE IND Approval: In June, the Company received UAE IND approval for NEO100, covering all three NEO100 programs across adult Phase 1 through Phase 2, as well as pediatric studies. The authorization extends NeOnc’s UAE footprint beyond NEO212 and complements ongoing U.S. development, where NEO100 holds FDA Orphan Drug, Fast Track and Rare Pediatric Disease designations. &nbsp;</li><li>NEO212 UAE IND Approval: Also in June, the Company secured UAE IND approval for NEO212, enabling Phase 2 evaluation of the Company’s oral perillyl alcohol-temozolomide conjugate in the United Arab Emirates. The clearance follows completion of the Phase 1 dose-escalation study and supports the continued clinical development of NEO212 in the United Arab Emirates. &nbsp;</li><li>FDA Feedback on NEO212 Development Program: In July, the Company received written feedback from the FDA regarding the continued development of NEO212, including its chemistry, manufacturing and controls program and the proposed transition from a capsule to a tablet formulation. NeOnc subsequently engaged with the FDA to discuss the next stage of clinical development. The Company is incorporating the FDA’s written feedback and meeting discussion into its proposed Phase 2 development strategy and expects to receive the official meeting minutes in August 2026. &nbsp;</li><li>NEO100 Phase 2a Topline Analysis Completed: The Company completed the topline analysis of its fully enrolled Phase 2a study evaluating intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma. NeOnc will present the results during an investor conference call and webcast on August 12, 2026. &nbsp;</li></ul>Strengthening Leadership and Capital Position<ul><li>Board Appointment: In July, the Company appointed Nasim Shomali to its Board of Directors, effective July 1, 2026. Ms. Shomali brings more than a decade of experience advising large organizations on corporate strategy, operating models and financial planning, grounded in formal training in biomedical engineering and finance. &nbsp;</li><li>Cash Position and Financial Flexibility: As of June 30, 2026, the Company had cash and cash equivalents of approximately $2.0 million. The Company also maintained an undrawn $10.0 million line of credit with HCWG, a related party, providing additional access to capital to support ongoing operations and clinical development, subject to the terms of the facility. &nbsp;</li><li>Capital Resources: The Company maintains access to several capital sources, including its equity purchase facility with Mast Hill Fund, LP, its $300 million shelf registration statement and its at-the-market offering program with BTIG, LLC and Alliance Global Partners. No shares were sold under either the Mast Hill facility or the ATM program during the second quarter of 2026. As of June 30, 2026, approximately $44.5 million remained available under the Mast Hill facility, subject to the terms, conditions and volume limitations of the agreement. &nbsp;</li></ul>Upcoming Investor Conference CallThe Company will host an investor conference call and webcast on Wednesday, August 12, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss topline Phase 2a results for intranasal NEO100 in recurrent IDH1-mutant high-grade glioma. A live webcast will be available at https://www.webcaster5.com/Webcast/Page/3151/54410 or <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.neonc.com,/">https://investors.neonc.com,</a> where a replay will be archived shortly following the conclusion of the call.Financial Results for Q2 2026<ul><li>G&amp;A expenses: General and administrative expenses decreased to $0.9 million from $1.0 million in Q2 2025, reflecting lower D&amp;O insurance premiums and reduced advertising, marketing and travel expenses, partially offset by increased business development costs. The year-over-year decrease reflects the Company’s continued focus on controlling corporate expenses while directing resources toward clinical development. &nbsp;</li><li>R&amp;D expenses: Research and development expenses were $2.6 million, compared with $0.7 million in Q2 2025. The increase reflects NeOnc’s continued investment in clinical execution, including the addition of clinical trial sites, expanded drug-product manufacturing, NEO212 patient recruitment, initiation of the NEO100-03 pediatric trial, and completion of data-lock and analysis activities for the NEO100 Phase 2a study. &nbsp;</li><li>Net loss: Net loss was $14.2 million, or $(0.58) per diluted share, compared with $5.7 million, or $(0.30) per diluted share, in Q2 2025. Approximately $5.7 million, or 40%, of the Company’s $14.1 million in total operating expenses consisted of noncash stock-based compensation. Excluding this noncash expense, total operating expenses were approximately $8.4 million. A reconciliation of this non-GAAP measure is provided below. &nbsp;</li><li>Cash used in operations: Net cash used in operating activities was $11,756,954 for the six months ended June 30, 2026, compared to $10,964,226 for the same period in 2025. The difference between cash used in operations and the net loss of $23,059,976 for the six-month period primarily reflects non-cash charges, including $8,384,311 of stock-based compensation. &nbsp;</li></ul>Reconciliation of GAAP Total Operating Expenses to Non-GAAP Total Operating Expenses Excluding Stock-Based Compensation (unaudited)<figure class="table"><table><tbody><tr><td>&nbsp;</td><td colspan="2">Three Months Ended June 30, 2026 &nbsp;</td></tr><tr><td>GAAP total operating expenses</td><td>$</td><td>14,069,887</td></tr><tr><td>Less: Non-cash stock-based compensation expense</td><td>&nbsp;</td><td>(5,651,913)</td></tr><tr><td>Non-GAAP total operating expenses excluding stock-based compensation</td><td>$</td><td>8,417,974</td></tr></tbody></table></figure> ABOUT NEONC TECHNOLOGIES HOLDINGS, INC.NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood-brain barrier. The company’s NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc’s lead programs include NEO100™, which is being evaluated in multiple Phase 1 and Phase 2 clinical studies, and NEO212™, which has completed Phase 1 dose escalation and is advancing toward Phase 2 development. NEO100 has received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations. The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California consisting of issued patents and pending applications related to NEO100, NEO212, and other products from the NeOnc patent family for multiple uses, including oncological and neurological conditions.For more about NeOnc and its pioneering technology, visit https://neonc.comImportant Cautions Regarding Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “intend,” “expect,” “plan,” “budget,” “forecast,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “evaluating,” or similar words. Statements that contain these words should be read carefully, as they discuss our future expectations, projections of future results of operations or financial condition, or other forward-looking information.Please refer to the “Risk Factors” section of our quarterly and annual reports on Form 10-Q and Form 10-K as filed with the Securities and Exchange Commission, along with other cautionary language in those reports and risk factors and other cautionary language in our subsequent filings with the Securities and Exchange Commission, which outline important risks and uncertainties. These may cause our actual results to differ materially from the forward-looking statements herein, including but not limited to the fact that results of preclinical studies and early clinical trials may not be predictive of results of future clinical trials, announced or published data from our clinical trials may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data, and our product candidates are in preclinical and clinical stages of development, are not approved for commercial sale and might never receive regulatory approval or become commercially viable.We assume no obligation to revise or update any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable securities laws and regulations.“NEO100” and “NEO212” are registered trademarks of NeOnc Technologies Holdings, Inc.Company Contact: info@neonc.comInvestor Contact: Jon Nugent Jon Nugent Communications jon@jonnugent.com 205-566-3026Source: NeOnc Technologies Holdings, Inc.2026 GlobeNewswire, Inc., source Press Releases

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

NeOnc (NTHI) reports Q2 2026 results, UAE IND approvals for NEO100/NEO212, board addition, and Aug. 12 NEO100 Phase 2a glioma topline data reveal

Space-Eyes and McKinley Acquisition Corp. Announce Definitive Business Combination Agreement to Deliver AI-Driven Counter Drone Technology and Geospatial Intelligence Worldwide

Space-Eyes to go public via SPAC merger with McKinley Acquisition Corp ($638M valuation), trading as CUAS on Nasdaq. Eric Trump joins as advisor

McKinley Acquisition Corp. - Ordinary Shares - Class A

Validation demonstrates QCIM core IP can accelerate FIPS 203, 204 and 205 under demanding operating conditions, advancing next-generation hardware for military, industrial, automotive, IoT, Physical AI and connected infrastructureVANCOUVER, BC, Aug. 7, 2026 /PRNewswire/ -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4747951-1&amp;h=3220365908&amp;u=https%3A%2F%2Fwww.btq.com%2F&amp;a=BTQ+Technologies+Corp.">BTQ Technologies Corp.</a>&nbsp;("BTQ"&nbsp;or the "Company") (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/btq-technologies-and-itri-complete-key-milestone-in-global-qcim-chip-roadmap-led-by-btq-and-ictk-302845917.html#financial-modal">BTQ</a>) (CBOE CA: BTQ), a global technology company building the trust infrastructure for the quantum era, is pleased to announce the successful completion of the first milestone of its multi-year collaboration with the Industrial Technology Research Institute ("ITRI") to validate BTQ's Quantum Compute-in-Memory ("QCIM") architecture for post-quantum cryptography.The collaboration with ITRI forms part of the global QCIM chip roadmap led by BTQ and ICTK Co., Ltd. ("ICTK") (KOSDAQ: 456010). The program brings together BTQ's cryptographic architecture, ICTK's secure semiconductor and physical unclonable function capabilities, and ITRI's advanced semiconductor design, integration and validation expertise.Completion of the first milestone demonstrated the QCIM architecture's ability to accurately and efficiently accelerate cryptographic operations across demanding operating conditions evaluated during the program. The results support the continued development of next-generation QCIM technology designed for future integration across military, industrial, automotive, Internet of Things, Physical AI and other connected devices, systems and infrastructure.The QCIM core IP demonstrated its crypto-agility by executing cryptographic operations associated with FIPS 203, FIPS 204 and FIPS 205, the post-quantum cryptography standards established by the U.S. National Institute of Standards and Technology. The architecture is also being developed to support additional post-quantum cryptographic algorithms as standards, customer requirements and security environments evolve.Milestone Highlights<ul><li>Completed the first technical milestone of BTQ and ITRI's multi-year QCIM collaboration &nbsp;</li><li>Validated the QCIM core within a TSMC 28-nanometre design environment &nbsp;</li><li>Demonstrated acceleration of cryptographic operations associated with FIPS 203, 204 and 205 &nbsp;</li><li>Confirmed the functional correctness and feasibility of the QCIM architecture &nbsp;</li><li>Demonstrated performance advantages and crypto-agility across multiple post-quantum algorithms &nbsp;</li><li>Advanced the program into its next phase of module-level integration, verification and validation</li></ul>"This milestone is an important technical and commercial step in the global QCIM roadmap being led by BTQ and ICTK," said Olivier Roussy Newton, CEO and Chairman of BTQ Technologies.&nbsp;"The results demonstrate that the QCIM architecture can accurately and efficiently accelerate multiple NIST-standardized post-quantum cryptographic algorithms under demanding conditions while maintaining the flexibility required to respond to evolving security standards. As post-quantum security moves from standardization toward implementation, organizations will require hardware that can deliver stronger cryptographic protection without creating unacceptable performance, power or deployment constraints," continued Roussy Newton. "The work completed with ITRI provides a stronger foundation for integrating QCIM into the devices and infrastructure supporting military, industrial, automotive, IoT and Physical AI systems."QCIM is BTQ's soft IP cryptographic accelerator architecture designed to support both classical and post-quantum cryptographic functions in a compact, low-power block. By executing cryptographic operations inside the memory subsystem, QCIM is designed to reduce latency, power consumption, and data movement while supporting crypto-agile security across a range of chip architectures and connected devices.The next-generation QCIM quantum-security chip is being developed for use across IoT, AI devices, industrial systems, secure elements, edge devices, and other connected infrastructure where device authentication, security performance, and long-term cryptographic resilience are becoming increasingly important.The program will now advance into its next phase, focused on module-level integration, verification and validation. This phase is intended to further evaluate how the QCIM core can be incorporated into broader system architectures while preserving functional correctness, interoperability and performance.For BTQ, completion of the first milestone represents an important step in advancing QCIM from architectural development toward commercial evaluation. Independent validation of the core design reduces technical risk and provides a stronger foundation for system-level integration, prospective customer demonstrations and discussions with semiconductor, infrastructure and device partners. The next phase is intended to generate the additional verification and integration data required to assess product configurations, customer-specific applications and the appropriate pathway toward fabrication and deployment. While further development remains, the milestone strengthens BTQ's ability to move QCIM commercialization efforts forward based on demonstrated technical performance rather than design assumptions."This milestone demonstrates meaningful progress in validating compute-in-memory architectures for post-quantum cryptography," said Dr. Chih-Cheng Lu, Manager of ITRI's Electronic and Optoelectronic System Research Laboratories.&nbsp;"The next phase will build on these results through module-level integration and verification, helping advance the architecture toward broader system implementation."BTQ intends to evaluate subsequent fabrication, demonstration and customer-evaluation activities based on the results of the integration and verification program, foundry availability, prospective customer requirements and broader commercial opportunities.Backed by ICTK's secure chip capabilities and ITRI's validation results, BTQ expects to ship test chips to key customers and strategic partners by year-end for performance and functional validation.About ITRI The Industrial Technology Research Institute (ITRI) is a world-leading R&amp;D organization dedicated to innovating a better future. Founded in 1973, ITRI has played a vital role in transforming Taiwan's industries from labor-intensive into innovation-driven. Over the years, ITRI has incubated hundreds of startups and spinoffs, including well-known companies such as UMC and TSMC. Headquartered in Taiwan, ITRI also operates offices in the U.S., Germany, the UK, Japan, and Thailand. For more information, please visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4747951-1&amp;h=4212932366&amp;u=https%3A%2F%2Fwww.itri.org%2Feng&amp;a=https%3A%2F%2Fwww.itri.org%2Feng">https://www.itri.org/eng</a>&nbsp;About BTQ BTQ Technologies Corp. (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/btq-technologies-and-itri-complete-key-milestone-in-global-qcim-chip-roadmap-led-by-btq-and-ictk-302845917.html#financial-modal">BTQ</a> | Cboe CA: BTQ) is a quantum technology company focused on accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio and deep technical expertise, BTQ is developing a full-stack, neutral-atom quantum computing platform spanning hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense.Connect with BTQ: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4747951-1&amp;h=322553990&amp;u=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttps%253A%252F%252Fwww.btq.com%252F%26esheet%3D53333139%26newsitemid%3D20230221005165%26lan%3Den-US%26anchor%3DWebsite%26index%3D11%26md5%3D70e03e23af16db5c7a85081be4383a7e&amp;a=Website">Website</a>&nbsp;|&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4747951-1&amp;h=1409183835&amp;u=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fbtqag%252Fabout%252F%26esheet%3D53333139%26newsitemid%3D20230221005165%26lan%3Den-US%26anchor%3DLinkedIn%26index%3D12%26md5%3D3f39a7c292e1c684e09c0babfdf5f1b3&amp;a=LinkedIn">LinkedIn</a>&nbsp;| <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4747951-1&amp;h=477458891&amp;u=https%3A%2F%2Fx.com%2FBTQ_Tech&amp;a=X%2FTwitter">X/Twitter</a>ON BEHALF OF THE BOARD OF DIRECTORS Olivier Roussy Newton CEO, ChairmanNeither Cboe Canada nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.Forward Looking InformationCertain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to: BTQ's collaboration with ITRI; the global QCIM chip roadmap; next generation QCIM technologies; the development, advancement, commercialization, integration, and timing of QCIM and its core IP and demonstrations and discussions thereof; the anticipated shipment of test chips to customers and strategic partners, including the expected timing thereof; and the business plans of the Company, including with respect to its research partnerships. Forward-looking statements or information often can be identified by the use of words such as "anticipate", "intend", "expect", "plan" or "may" and the variations of these words are intended to identify forward-looking statements and information.The Company has made numerous assumptions including among other things, assumptions about successful completion of future integration, verification and validation activities, continued collaboration among BTQ, ICTK and ITRI, availability of foundry capacity and semiconductor development resources, continued demand for post-quantum security technologies, successful development of QCIM technology, successful fabrication and testing of future QCIM chips, customer interest in evaluating QCIM solutions, availability of technical, financial and commercial resources required to advance commercialization, general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and quantum computing industry generally. The foregoing list of assumptions is not exhaustive.Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: future integration, verification or validation activities; the performance of QCIM technology; fabrication, testing or deployment activities; foundry availability, semiconductor supply chains or development timelines; customer evaluations; commercialization efforts; the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.SOURCE BTQ Technologies Corp.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.<img src="https://rt.prnewswire.com/rt.gif?NewsItemId=VA21656&amp;Transmission_Id=202608070730PR_NEWS_USPR_____VA21656&amp;DateId=20260807" alt="">

BTQ Technologies and ITRI Complete Key Milestone in Global QCIM Chip Roadmap Led by BTQ and ICTK

BTQ validates QCIM chip architecture with ITRI, accelerating FIPS 203/204/205 post-quantum standards; test chips shipping to customers by year-end

BTQ Technologies Corp

<h2 class="article-sub-headline">Rail Inspection Technology Pioneer to Operate as an Independent, Privately Held Company Under the DuosTI Brand; Javier Acosta Appointed President</h2>JACKSONVILLE, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Qjtahl5y-O8s5mJfi-8_LsOpKPvQlgFYXU7rZIYD5iWfoSatZtZ2HBByLwy4f4aiXfbXsgaRUnc-ynkWiVaDYvGOoyyu9hqRd90B08_DDvKdlWV5FSFlhIxiVcAumZTL">Duos Technologies Group, Inc.</a> (“Duos” or the “Company”) (<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=N2msGntF-j71LikrgjQwNLBxaKoXOcUtcYg7tjW-gojQO5qRMWzUxV4_B8E68bbYxzrMpk259SaE5K6vbr7x3CECqtfsHM5AP5J9AUjP-2I=">Nasdaq: DUOT</a>), a leading provider of adaptive, modular, and scalable Edge Data Center solutions, today announced that it has completed the sale of its wholly owned rail technology subsidiary, Duos Technologies, Inc. (“DTI”), to Sandbank Acosta, LLC, a Florida limited liability company. Effective with the closing, DTI operates as an independent, privately held company under the DuosTI brand, led by newly appointed President Javier Acosta.The transaction, which closed on August 5th, 2026 with effect as of June 30th, 2026, returns Duos’ original operating business to private ownership as a focused railroad technology enterprise. DTI is a pioneer in machine vision and artificial intelligence-based inspection of moving trains and operates the largest installed base of Railcar Inspection Portals (RIP®) in North America, serving major carriers across the United States, Canada and Mexico. The Company believes DTI holds an extensive patent portfolio covering wayside scanning and AI defect detection and maintains the largest image database of railcar components in the world.“DTI built the technology that put Duos on the map, and its Railcar Inspection Portals remain the standard for AI-driven train inspection in North America,” said Doug Recker, Chief Executive Officer of the Company. “This transaction completes the strategic repositioning we announced earlier this year, placing the rail business with owners who are singularly focused on its growth while allowing Duos to dedicate its full capital and management attention to scaling our Edge Data Center and AI infrastructure platforms. We wish Javier and the DuosTI team every success and look forward to supporting a smooth transition.”“I had the privilege of leading the commercialization and field deployment of the Railcar Inspection Portal across the United States, Canada and Mexico, and I am honored to return to lead this exceptional team into its next chapter,” said Javier Acosta, President of DTI. “As DuosTI, we return to our roots as a focused railroad technology company. With the largest installed base of inspection portals in North America, a deep patent portfolio and an unmatched image database, we are well positioned to expand the reach of our inspection services for our railroad customers and the broader industry.”In connection with the closing, Adrian Goldfarb, the Company’s interim Chief Financial Officer, has stepped down as President of DTI, a role he had held since March 2026 to oversee the business and the divestiture process, with Mr. Acosta assuming the office of President. Mr. Goldfarb holds a 50% membership interest in Sandbank Acosta, LLC, and the sale was accordingly reviewed and approved by the Company’s Board of Directors as a related-party transaction, supported by an independent fairness opinion process undertaken in the second quarter of 2026.The divestiture completes the strategic repositioning announced by Duos in March 2026 and enables the Company to concentrate its resources on its Edge Data Center and AI infrastructure businesses through Duos Edge AI, Inc. and Duos Technology Solutions, Inc. Duos will provide certain transition services to DTI for a period following the closing to support continuity for DTI’s customers and employees.For additional information about the Company, please visit: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=mkEXybenhOoYcujR58VFvFuTUd5-FVRukMVenSL0r71XqY8L4JD3AfxxaIEwn8c4fY-uw7Xo7Izc7lY9kIQN4ojK1gbpO9H6_doU29zI7Ld8AUzdNmL_dIG8dbw8ud7P">www.duostechnologies.com</a> | <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=mkEXybenhOoYcujR58VFvIb4GpxqIDRIBRnGjV97naF8doQotwbR4Hx-OCXoIxCA0yN7B7gBbYY-tQQ6DBfZBg==">www.duosedge.ai</a>.About Duos Technologies Group, Inc. Duos Technologies Group, Inc. (<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=N2msGntF-j71LikrgjQwNDTVLtwe_vmrR1dpgE7CO4dszKEQtiyeSePorPPDi8StXbmsTrMUQiNFnD_1EsotlJeQKcY2PpU_VR0k6zKH-ik=">Nasdaq: DUOT</a>), based in Jacksonville, Florida, is focused on providing and managing modular data center colocation facilities and infrastructure solutions. Through its wholly owned subsidiaries Duos Edge AI, Inc., and Duos Technology Solutions, Inc. the Company delivers high function computing infrastructure at the “Edge” designed to support high power computing facilities suitable for AI and Enterprise Computing. Duos is strategically focused on scaling its edge data center platforms in conjunction with its data center infrastructure solutions business. It provides manufacturer-agnostic sourcing, and fulfillment services to support efficient deployment of data centers and IT environments. Together, these platforms position the Company to address the growing demand for distributed digital infrastructure, while continuing to support legacy applications in Tier 3 and Tier 4 markets. &nbsp;For more information, visit&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=mkEXybenhOoYcujR58VFvHpZkvTM4ZgwZ1aynCUSR5XHD7IFMHGf3ZzLkfI4y40W982nPT0u3Y9kTlzkFWUHhLBoM8Iv3_kVah-fgZqRa8M=">www.duostech.com</a> and <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=mkEXybenhOoYcujR58VFvD3oMU7sBNKwY0UWoHJ3YrsCcEfGS2IbEozbyftL4CTyyQv5ZcRsjo7Jaqt5OCscHA==">www.duosedge.ai</a>.Forward-Looking Statements This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated" and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. All forward-looking statements attributable to Duos Technologies Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.Contacts Investor Relations Tom Colton &amp; Greg Bradbury Gateway Group, Inc. +1 949-574-3860 | <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=GNXXw-MPr2VJV5_b4yNYKMVfYtKw_k9V4kW3LTn0zImuwzkI3khCco98CCvjSZWZ0eY2emZYgDy4_DMHO2mN8HZOPXzrKZ6I8RaoQylnFu4=">DUOT@duostech.com</a>This press release was published by a CLEAR® Verified individual.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Duos Technologies Group Completes Sale of Duos Technologies, Inc. to Sandbank Acosta, LLC

Duos Technologies sells rail subsidiary DTI to Sandbank Acosta LLC, forming independent DuosTI led by new President Javier Acosta

<h3>Community, business, education, and industry leaders invited to tour new operational edge infrastructure supporting connectivity, AI readiness, and digital growth across Waco and the broader Central Texas region</h3>WACO, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=TD_cg_KzIGQtmVxijzUPDHTsODKpVnZXyJXZQELU_evdP_nASKqfMiYsFg1qkhIP-N_wsc_FdDxpTugpeEnf0DETTTH5ssG-sSzLrk0T29Y=">Duos Edge AI, Inc</a>. (“Duos Edge AI”), a subsidiary of <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=TD_cg_KzIGQtmVxijzUPDFs2bqeNjWYs7guuD69-aoZKu7hm7IbYSVqv2UfWDzm83MSXvcaKEhiFYtM-CJMPPXfy9uhzEuOt4hx-T6alljXcY07faOKDCfY42yaKm1F1">Duos Technologies Group, Inc.</a> (Nasdaq: DUOT), will host an open house in Waco, Texas on Thursday, May 21, 2026, from 11:00 AM to 1:00 PM CT, to showcase its newly operational Edge Data Center (“EDC”) infrastructure serving <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=b1B1kA4T2A3rezCuP5j_KLWBofYtFVx7RoFkKeG3BtLzaMNvnUljuZKrWis6Gc_O7Gyiddq96HA0aQIzlm2Edg4wS8MMI8-8EEDvuVzvAc2I1CP_UXR7jSVkJWYUyX7E">Region 12 Education Service Center</a>, Waco, and the broader Central Texas market.Event DetailsDate: Thursday, May 21, 2026Time: 11:00 AM – 1:00 PM CTLocation: Waco EDC 2101 W. Loop 340 Waco, TX 76712RSVP: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=UPLDNiJZunp5xfLQXBxYGsVBEEPNul7zl6G59dHGM1aylzk6jUa4PhLHSh9H6d-4N0xRCaROiUo8YnNBZabi-bzdHt7cWJ6YdO-8DSxg33uo49rIKMqiHeV5rocblhQz9QzOR6QjSVgVnnwubhtkgw==">Secure Your Spot</a>The open house will provide invited guests, partners, community leaders, business representatives, education stakeholders, and industry representatives an opportunity to explore how edge data centers enable faster connectivity, localized computing power, AI readiness, and long-term digital growth.The Waco deployment is designed to serve as a highly secure, scalable, local computing hub supporting high-performance compute, network infrastructure, artificial intelligence workloads, education technology, telemedicine, electronic health record systems, enterprise applications, and disaster recovery solutions. The facility will support 77 school districts and 12 counties across the Region 12 footprint. Guests are encouraged to attend, tour the facility, and learn more about Duos Edge AI and the growing role of EDCs.This deployment represents a significant step in Duos Edge AI’s continued rollout of modular edge data centers designed to bring high-performance computing, low-latency connectivity, and scalable digital infrastructure closer to where data is created and consumed.“Waco plays a key role in Duos Edge AI’s growth strategy,” said <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=f5y1Iq-PZeIT0rCa36O4EF-tsBFTQdoR8RpwUzWz3ipEoycMAZT2J6aWOzqO1_cnpxTX2yEVXGYOj7cmkldfSrqsrbhbuvEE1M0ANW3WdM4=">Doug Recker</a>, CEO of Duos Edge AI and Duos Technologies Group, Inc. “With this deployment, we’re delivering reliable, localized computing resources closer to the schools, businesses, carriers, and communities that rely on them. We’re honored to contribute to the advancement of digital infrastructure in Waco and across Central Texas.”The event will highlight how Duos Edge AI’s modular EDC model can be rapidly deployed, seamlessly integrated with existing network infrastructure, and positioned closer to end users than traditional data center environments. By bringing compute power to the edge, Duos Edge AI is helping reduce latency, improve service readiness, and support the growing demand for real-time applications across education, healthcare, business, mobility, and emerging AI use cases.To learn more about Duos Edge AI, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=seK6cx_F9mDSyPce0b_VHauHi5QczVzTsS7xf9UcFBeqFCFui2SKyfZN3tA2z88HdNaOGmjIbRq1Pi9IraWpizGGFdYS9IAuDFUExOrwZeM=">www.duosedge.ai</a>.To learn more about Duos Technologies Group, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=seK6cx_F9mDSyPce0b_VHfR7qh6cP8482eQfRY35oLuMGXzmO0H41DFgT8dSk9JH-3-n-5l1bEXJXwAfPxfJl6mCsbfLLUYn7WfmyG7TWUM=">www.duostech.com</a>.About Duos Technologies Group, Inc.Duos Technologies Group, Inc. (Nasdaq: DUOT), based in Jacksonville, Florida, through its wholly owned subsidiaries, Duos Technologies, Inc., Duos Edge AI, Inc., and Duos Energy Corporation, designs, develops, deploys and operates intelligent technology solutions for Machine Vision and Artificial Intelligence (“AI”) applications including real-time analysis of fast-moving vehicles, Edge Data Centers, and power consulting. For more information, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=seK6cx_F9mDSyPce0b_VHS9KJ2eBNASk5fhUINr8g5hiE89D2mluMRI21Ket1UOFBxLqwA6T5QXboOJUgnEb272GKcYEyMWPkBJkZHGGAgM=">www.duostech.com</a>, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=seK6cx_F9mDSyPce0b_VHdn6e7y-IFKbbpqkRsZuXh2ZpD9Oph5TP5r-M-HTmPr52zYS3KJnu_6CyR2G1m0fY3g0Mu34xFEA9yoxsRw8xZI=">www.duosedge.ai</a> and <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=seK6cx_F9mDSyPce0b_VHeGrH2MozXcAJHthwx3Wy7eSDd7n7Ypa7mbP_cPTsSYbtRZCHjdf7n9RcB6x0MfiKm7k7ikxpOM5gtVmdZrhn3E=">www.duosenergycorp.com</a>.About Duos Edge AI, Inc.Duos Edge AI, Inc. is a subsidiary of Duos Technologies Group, Inc. (Nasdaq: DUOT). Duos Edge AI's mission is to bring advanced technology to underserved communities, particularly in education, healthcare and rural industries, by deploying high-powered edge computing solutions that minimize latency and optimize performance. Duos Edge AI specializes in high-function Edge Data Center (“EDC”) solutions tailored to meet evolving needs in any environment. By focusing on providing scalable IT resources that seamlessly integrate with existing infrastructure, its solutions expand capabilities at the network edge, ensuring data uptime and onsite services. With the ability to provide 100 kW+ per cabinet, rapid 90-day deployment, and continuous 24/7 data services, Duos Edge AI aims to position its edge data centers within 12 miles of end users or devices, significantly closer than traditional data centers. This approach enables timely processing of massive amounts of data for applications requiring real-time response and supporting current and future technologies without large capital investments. For more information, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=seK6cx_F9mDSyPce0b_VHQTgVuWmFGrYbUx1NKVTOyiOn7lXaHHpaaW2NNHtZz1IcfDiNUS6qR5a5u-cKos5-bG6wZ2O8iMdN0y0TN1zBEM=">www.duosedge.ai</a>.About Greater Waco Chamber of CommerceThe Greater Waco Chamber of Commerce is a business leadership organization supporting economic development, workforce and talent initiatives, public policy, business growth, and community advancement across the Greater Waco area. The Chamber is located in Waco, Texas and works to strengthen the region as a place for businesses, residents, and communities to grow. For more information, visit www.wacochamber.com.Media ContactDuos Edge AI iMiller Public Relations +1.914.315.6424 duosedge@imillerpr.comSource: Duos Technologies Group, IncReleased May 12, 2026Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.